分析安罗替尼靶向治疗联合化疗治疗晚期乳腺癌的疗效

打开文本图片集

【摘要】目的：分析晚期乳腺癌行安罗替尼靶向治疗联合化疗的临床疗效。方法：截选2021年1月—2023年1月100例晚期乳腺癌患者，按照奇偶数法将其分为常规组（50例，化疗）和联合组（50例，安罗替尼靶向治疗+化疗），比较两组血清肿瘤标志物、症状积分、毒副反应与治疗效果。结果：治疗后，联合组CEA、CA153及CA125水平比常规组低（P

【关键词】晚期乳腺癌；安罗替尼；靶向治疗；化疗

To analyze the efficacy of anlotinib targeted therapy combined with chemotherapy in the treatment of advanced breast cancer

REN Xiaoqiong

Pingliang Hospital of Traditional Chinese Medicine， Pingliang， Gansu 744000， China

【Abstract】Objective：To analyze the clinical efficacy of anlotinib targeted therapy combined with chemotherapy for advanced breast cancer.Methods：From January 2021 to January 2023，100 patients with advanced breast cancer were selected and divided into the conventional group （50 cases，chemotherapy） and the combined group （50 cases，anlotinib targeted therapy + chemotherapy） according to the odd-even method，and the serum tumor markers，symptom scores，toxic and side effects and therapeutic effects of the two groups were compared.Results：After treatment，the levels of CEA，CA153 and CA125 in the combined group were lower than those in the conventional group （P

【Key Words】Advanced breast cancer； Anlotinib； Targeted therapy； Chemotherapy

近年来，乳腺癌在全球范围内的发病率呈现出不断增加的趋势，成为女性最常见的恶性肿瘤之一[1]。（剩余4438字）